Maysa Baroud

ORCID: 0000-0002-0227-1985
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Bacterial biofilms and quorum sensing
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Bacterial Infections and Vaccines
  • Migration, Health and Trauma
  • Pneumonia and Respiratory Infections
  • Middle East Politics and Society
  • Global Public Health Policies and Epidemiology
  • Islamic Studies and History
  • Global Health and Epidemiology
  • Patient Satisfaction in Healthcare
  • Trade Secret Protection Methods
  • Antifungal resistance and susceptibility
  • Electronic Health Records Systems
  • Middle East and Rwanda Conflicts
  • Nephrotoxicity and Medicinal Plants
  • Chronic Disease Management Strategies
  • Streptococcal Infections and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Healthcare Policy and Management
  • Education and experiences of immigrants and refugees
  • Healthcare professionals’ stress and burnout
  • Pharmaceutical Practices and Patient Outcomes
  • Oral microbiology and periodontitis research
  • Migration, Refugees, and Integration

American University of Beirut
2012-2018

American University of Beirut Medical Center
2012

eHealth can positively impact the efficiency and quality of healthcare services. Its potential benefits extend to patient, provider, organization. Primary (PHC) settings may particularly benefit from eHealth. In these settings, provider readiness is key successful implementation. Accordingly, it necessary explore providers use tools. Therefore, purpose this study was assess working in PHC centers Lebanon tools.A self-administered questionnaire used participants' socio-demographics, computer...

10.1186/s12913-016-1896-2 article EN cc-by BMC Health Services Research 2016-11-10

Carbapenem resistance has been encountered globally with poor outcome of infected patients. NDM-1 (New Delhi metallo-beta-lactamase) gene containing organisms have emerged and are now spreading in all continents. This is the first report Iraqi patients referred to Lebanon from whom carbapenem resistant Enterobacteriaceae were recovered. The genes involved bla-OXA-48 novel NDM-1. highlights alarming introduction such among Enterobacteriaecae this country.

10.3855/jidc.2340 article EN cc-by The Journal of Infection in Developing Countries 2012-01-27

Abstract Background This study determined macrolide resistance genotypes in clinical isolates of Streptococcus pneumoniae from multiple medical centers Lebanon and assessed the serotype distribution relation to these mechanism(s) source isolate recovery. Methods Forty four resistant 21 susceptible S. were tested for antimicrobial susceptibility according CLSI guidelines (2008) underwent molecular characterization. Serotyping was performed by Multiplex PCR-based deduction using CDC protocols....

10.1186/1476-0711-11-2 article EN cc-by Annals of Clinical Microbiology and Antimicrobials 2012-01-01

Low job satisfaction is linked to higher staff turnover and intensified shortages in healthcare providers (HCP). This study investigates the level of, factors associated with, HCP national primary (PHC) network Lebanon. The adopts a cross-sectional design survey at 99 PHC centres distributed across country between October 2013 May 2014. questionnaire consisted of four sections: socio-demographics/professional background, employment characteristics, (Measure Job Satisfaction scale)...

10.1111/hsc.12454 article EN Health & Social Care in the Community 2017-06-18

This study assesses the potential effect of micafungin, an antifungal agent known to inhibit 1,3-β-D-glucan synthesis in Candida albicans, on biofilm formation selected Pseudomonas aeruginosa isolates by decreasing extracellular matrix β-D-glucan forming units. The optimal therapeutic dose 10 mg ml−1 micafungin production was monitored vitro using a microtiter plate assay. Phenotypic reduction significant (based average optical density; p < 0.05) most isolates. Moreover, relative gene...

10.1080/08927014.2013.816299 article EN Biofouling 2013-07-24
Coming Soon ...